INS and diabetes mellitus: This insight is particularly relevant in the broader context of beta-cell replacement and diabetes management, where therapeutic strategies often focus on preserving or enhancing residual insulin secretion without always accounting for the impact of insulin sensitivity on metabolic outcomes.